David Cervi

1.2k total citations
21 papers, 948 citations indexed

About

David Cervi is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, David Cervi has authored 21 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Hematology and 8 papers in Oncology. Recurrent topics in David Cervi's work include Inflammatory Biomarkers in Disease Prognosis (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Platelet Disorders and Treatments (4 papers). David Cervi is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Platelet Disorders and Treatments (4 papers). David Cervi collaborates with scholars based in United States, Canada and Slovakia. David Cervi's co-authors include Giannoula Klement, Elise R. Bender, Tai‐Tung Yip, Joseph E. Italiano, Vladimir N. Podust, Abdo Abou-Slaybi, Nava Almog, Judah Folkman, Flávia Cassiola and Mark W. Kieran and has published in prestigious journals such as Blood, Cancer Cell and Cancer Research.

In The Last Decade

David Cervi

21 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Cervi United States 13 554 377 281 226 128 21 948
Habib Boukerche France 20 809 1.5× 504 1.3× 259 0.9× 196 0.9× 251 2.0× 33 1.6k
Veronica A. Carroll United Kingdom 15 595 1.1× 160 0.4× 99 0.4× 530 2.3× 125 1.0× 23 1.1k
Joanna W. Ho Hong Kong 15 638 1.2× 283 0.8× 68 0.2× 281 1.2× 109 0.9× 16 1.1k
Brian Riesenberg United States 13 317 0.6× 356 0.9× 91 0.3× 125 0.6× 321 2.5× 17 857
S. Virudachalam United States 11 640 1.2× 356 0.9× 100 0.4× 178 0.8× 143 1.1× 17 987
Raphaël Leblanc France 14 535 1.0× 290 0.8× 79 0.3× 175 0.8× 119 0.9× 22 819
Vildan Yasasever Türkiye 19 435 0.8× 458 1.2× 42 0.1× 195 0.9× 204 1.6× 53 957
Yoshihiro Mitsuhashi Japan 10 866 1.6× 455 1.2× 56 0.2× 409 1.8× 63 0.5× 11 1.2k
Sujatha Jagadeeswaran United States 12 465 0.8× 360 1.0× 50 0.2× 197 0.9× 100 0.8× 16 973
Catherine J. Haskell United States 6 454 0.8× 162 0.4× 86 0.3× 125 0.6× 180 1.4× 6 834

Countries citing papers authored by David Cervi

Since Specialization
Citations

This map shows the geographic impact of David Cervi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cervi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cervi more than expected).

Fields of papers citing papers by David Cervi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Cervi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cervi. The network helps show where David Cervi may publish in the future.

Co-authorship network of co-authors of David Cervi

This figure shows the co-authorship network connecting the top 25 collaborators of David Cervi. A scholar is included among the top collaborators of David Cervi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Cervi. David Cervi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Epperly, Rebecca, Wayne L. Furman, Melissa Hines, et al.. (2019). Secondary hemophagocytic syndrome after autologous hematopoietic cell transplant and immune therapy for neuroblastoma. Pediatric Blood & Cancer. 66(11). e27964–e27964. 2 indexed citations
2.
Jakubı́ková, Jana, Sophia Adamia, Maria Kost‐Alimova, et al.. (2011). Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. Blood. 117(17). 4409–4419. 122 indexed citations
3.
Jakubı́ková, Jana, David Cervi, Melissa Ooi, et al.. (2011). Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. Haematologica. 96(8). 1170–1179. 63 indexed citations
4.
Cervi, David, Brian J. Pak, Linda Sugar, et al.. (2010). Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, Platelet Factor-4. BMC Cancer. 10(1). 258–258. 13 indexed citations
5.
Cervi, David, et al.. (2010). Vascular Endothelial Growth Factor—A Positive and Negative Regulator of Tumor Growth. Cancer Research. 70(3). 863–867. 28 indexed citations
6.
7.
Blotta, Simona, Pierfrancesco Tassone, Rao Prabhala, et al.. (2009). Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance. Blood. 114(15). 3276–3284. 33 indexed citations
8.
Pietramaggiori, Giorgio, Saja Scherer, David Cervi, Giannoula Klement, & Dennis P. Orgill. (2008). Tumors Stimulate Platelet Delivery of Angiogenic Factors in Vivo. American Journal Of Pathology. 173(6). 1609–1616. 29 indexed citations
9.
Klement, Giannoula, Tai‐Tung Yip, Flávia Cassiola, et al.. (2008). Platelets actively sequester angiogenesis regulators. Blood. 113(12). 2835–2842. 261 indexed citations
10.
Cervi, David, Tai‐Tung Yip, Nandita Bhattacharya, et al.. (2007). Platelet-associated PF-4 as a biomarker of early tumor growth. Blood. 111(3). 1201–1207. 120 indexed citations
11.
Klement, Giannoula, David Cervi, Tai‐Tung Yip, Judah Folkman, & Joseph E. Italiano. (2006). Platelet PF-4 Is an Early Marker of Tumor Angiogenesis.. Blood. 108(11). 1476–1476. 1 indexed citations
12.
Folkman, Judah, et al.. (2006). The Platelet Angiogenesis Proteome for Early Detection of Cancer. The FASEB Journal. 20(4). 1 indexed citations
13.
Cervi, David, Yuval Shaked, Tatiana Usenko, et al.. (2006). Enhanced natural-killer cell and erythropoietic activities in VEGF-A–overexpressing mice delay F-MuLV–induced erythroleukemia. Blood. 109(5). 2139–2146. 22 indexed citations
14.
Shaked, Yuval, Francesco Bertolini, S. Man, et al.. (2005). Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesisImplications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell. 7(1). 101–111. 172 indexed citations
15.
Shi, Yonghong, Jelena Tomić, David Cervi, et al.. (2004). Effect of Serum and Antioxidants on the Immunogenicity of Protein Kinase C-Activated Chronic Lymphocytic Leukemia Cells. Journal of Immunotherapy. 28(1). 28–39. 19 indexed citations
16.
17.
Cervi, David, et al.. (2004). Direct transcriptional regulation of MDM2 by Fli-1. Oncogene. 24(6). 962–969. 27 indexed citations
18.
Cotter, David A., Dana C. Mahadeo, David Cervi, et al.. (2000). Environmental Regulation of Pathways Controlling Sporulation, Dormancy and Germination Utilizes Bacterial-like Signaling Complexes in Dictyostelium discoideum. Protist. 151(2). 111–126. 15 indexed citations
19.
Kishi, Yoshiro, et al.. (2000). Glucose-Induced Pathways for Actin Tyrosine Dephosphorylation during Dictyostelium Spore Germination. Experimental Cell Research. 261(1). 187–198. 8 indexed citations
20.
Cervi, David, et al.. (1999). Differential in vitro activation and deactivation of cysteine proteinases isolated during spore germination and vegetative growth of Dictyostelium discoideum. European Journal of Biochemistry. 266(1). 132–142. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Habib Boukerche Breakdown of academic impact, for papers by Veronica A. Carroll Breakdown of academic impact, for papers by Joanna W. Ho Breakdown of academic impact, for papers by Brian Riesenberg Breakdown of academic impact, for papers by S. Virudachalam Breakdown of academic impact, for papers by Raphaël Leblanc Breakdown of academic impact, for papers by Vildan Yasasever Breakdown of academic impact, for papers by Yoshihiro Mitsuhashi Breakdown of academic impact, for papers by Sujatha Jagadeeswaran Breakdown of academic impact, for papers by Catherine J. Haskell
Rankless by CCL
2026